Home › Funds › Hillman Capital Management, Inc. › BIIB

Hillman Capital Management, Inc. position in BIIB

BIOGEN INC · Health Care

Hillman Capital Management, Inc. reported holding 22,902 shares of BIIB (BIOGEN INC) in its Q3 2026 13F filing — a position valued at US$5.2M, representing 3.87% of its reported portfolio and ranking #3 among its reported holdings. Hillman Capital Management, Inc. has disclosed BIIB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)22.90K sh
Reported value held$5.17M
Portfolio Weight3.87%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Hillman Capital Management, Inc.'s BIIB position evolved

Hillman Capital Management, Inc. first disclosed a stake in BIIB in Q3 2023 at 34,306 shares (US$8.8M). The position peaked in Q4 2023 at 34,476 shares, worth US$8.9M. Across 13 filings, Hillman Capital Management, Inc. increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 22,902 shares valued at US$5.2M — a reduction of -1,091 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 34.31K $8.82M New
Q4 2023 34.48K $8.92M Hold
Q1 2024 35.79K $7.72M Add
Q2 2024 35.95K $8.33M Hold
Q3 2024 35.25K $6.83M Reduce
Q4 2024 43.07K $6.59M Add
Q1 2025 44.02K $6.02M Add
Q2 2025 41.97K $5.27M Reduce
Q3 2025 38.35K $5.37M Reduce
Q4 2025 30.52K $5.37M Reduce
Q1 2026 29.54K $5.42M Reduce
Q2 2026 23.99K $5.18M Reduce
Q3 2026 22.90K $5.17M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 20 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.43B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

All BIIB fund holders →

FAQ

How long has Hillman Capital Management, Inc. held BIIB?

Hillman Capital Management, Inc. has disclosed BIIB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Hillman Capital Management, Inc.'s current position in BIIB?

As of Q3 2026, Hillman Capital Management, Inc. holds 22.90K shares of BIIB (BIOGEN INC), valued at $5.17M, representing 3.87% of its reported portfolio and ranking #3.

Has Hillman Capital Management, Inc. been buying or selling BIIB?

In the latest 13F filing (Q3 2026), Hillman Capital Management, Inc. reduced its position in BIIB. The position peaked in Q4 2023 at 34.48K shares.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.